BMC, BUSM and JIPMER to analyze on tuberculosis jointly Boston INFIRMARY and Boston University College of Medication are partnering with the Jawaharlal Institute of Postgraduate Medical Education and Analysis to review tuberculosis . This study is backed by a five-year, $2.5 million grant from the Indo-U.S. Vaccine Actions Plan . The joint system, located in Pondicherry, India, will set up cohorts of TB sufferers and their home contacts, or individuals who reside in the same home who’ve been exposed to the condition. This allows the researchers to look for the influence of co-morbidities, such as for example smoking, alcoholism, worm attacks, diabetes mellitus and malnutrition on the chance of developing TB and individual's response to treatment.Types of other projects that have benefited from FP7 funding include: An educational and industrial partnership spanning the Irish Sea which secured -705,000 funding through the FP7 Marie Curie Sector Academia Partnerships and Pathways scheme for a fresh approach to skin cancers. HIPODERM combines expertise from the Welsh College of Pharmacy, the Welsh firm An-eX Analytical Services and two Irish companions, the Pharmaceutical and Molecular Biotechnology Research Centre at Waterford Institute of Technology and the business EirGen Pharma. Collaborative research projects led by experts from the Cardiff College of Computer Science and Informatics with partners at the Universities of Oxford and Cambridge, and additional European universities.